Literature DB >> 21684315

Analysis of the influence of two CD24 genetic variants in Crohn's disease and ulcerative colitis.

Lina-Marcela Diaz-Gallo1, Luz María Medrano, María Gómez-García, Carlos Cardeña, Luis Rodrigo, Juan Luis Mendoza, Carlos Taxonera, Antonio Nieto, Guillermo Alcain, Ignacio Cueto, Miguel A López-Nevot, Elena Urcelay, Javier Martin.   

Abstract

The aim of this study was to evaluate the possible implication of CD24 gene in the genetic predisposition to inflammatory bowel disease (IBD). Our study population consisted of 1321 female Spanish individuals (369 Crohn's disease [CD] patients, 323 ulcerative colitis [UC] patients, and 629 healthy matched controls). Two putative functional polymorphisms, a C to T coding polymorphism (rs8734) and a TG deletion in the 3' untranslated region (rs3838646), were used as CD24 genetic markers and genotyped using a Taqman 5' allelic discrimination assay. The "del" allele of the dinucleotide deletion was associated with an increased risk of CD (odds ratio = 1.61, 95% confidence interval = 1.17-2.21, p(FDR) = 6.4E-03) but not with UC. Moreover, this allele was significant associated with the age of CD diagnosis between 17 and 40 years, the ileocolonic location, and the inflammatory behavior of CD. We observed no significant differences between the allelic or genotypic frequencies of the A57V polymorphism in our studied IBD cohort. Our results suggest that the rs3838646 CD24 polymorphism is part of the genetic background of CD.
Copyright © 2011 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21684315     DOI: 10.1016/j.humimm.2011.05.028

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  8 in total

Review 1.  CD24: from a Hematopoietic Differentiation Antigen to a Genetic Risk Factor for Multiple Autoimmune Diseases.

Authors:  Yixin Tan; Ming Zhao; Bo Xiang; Christopher Chang; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2016-02       Impact factor: 8.667

2.  CD24 genetic variants contribute to overall survival in patients with gastric cancer.

Authors:  Zhi-Fang Jia; Li-Zhong Wang; Xue-Yuan Cao; Chuan Wang; Dong-Hui Cao; Xing Wu; Li-Li You; Mei-Shan Jin; Yin-Ping Wang; Bao-Sen Zhou; Jing Jiang
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

Review 3.  Associations between CD24 gene polymorphisms and inflammatory bowel disease: A meta-analysis.

Authors:  Xiao-Li Huang; Dong-Hua Xu; Guo-Pin Wang; Shu Zhang; Cheng-Gong Yu
Journal:  World J Gastroenterol       Date:  2015-05-21       Impact factor: 5.742

4.  NDRG2 down-regulation and CD24 up-regulation promote tumor aggravation and poor survival in patients with gallbladder carcinoma.

Authors:  Shi-peng Song; Sheng-bin Zhang; Rui Liu; Li Yao; Yu-qin Hao; Ming-mei Liao; Yang-de Zhang; Zhe-hai Li
Journal:  Med Oncol       Date:  2011-12-02       Impact factor: 3.064

5.  Polymorphisms of the CD24 Gene Are Associated with Risk of Multiple Sclerosis: A Meta-Analysis.

Authors:  Georgia G Braliou; Katerina G Pantavou; Panagiota I Kontou; Pantelis G Bagos
Journal:  Int J Mol Sci       Date:  2015-06-01       Impact factor: 5.923

6.  CD24 expression does not affect dopamine neuronal survival in a mouse model of Parkinson's disease.

Authors:  Simon R W Stott; Shaista Hayat; Tom Carnwath; Shaady Garas; Jonathan P Sleeman; Roger A Barker
Journal:  PLoS One       Date:  2017-02-09       Impact factor: 3.240

7.  CD24 single nucleotide polymorphisms and cancer risk.

Authors:  Shushan Yan; Donghua Xu; Tao Jiang; Ping Wang; Yin Yin; Xiaochen Wang; Changjiang Hua; Bin Zhang; Zengcai Li; Lei Lu; Xianzhong Liu; Bingji Wang; Donghua Zhang; Rongsheng Zhang; Beicheng Sun; Xuan Wang
Journal:  Tumour Biol       Date:  2014-06-04

8.  Genetic variants associated with Crohn's disease.

Authors:  Sonia Michail; Gilberto Bultron; R William Depaolo
Journal:  Appl Clin Genet       Date:  2013-07-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.